Full Text View
Tabular View
No Study Results Posted
Related Studies
WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides
This study is ongoing, but not recruiting participants.
Study NCT00349674   Information provided by Hospices Civils de Lyon
First Received: July 6, 2006   Last Updated: October 9, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Systemic Wegener's Granulomatosis
Additional conditions recognized in this trial
Vasculitis
Wegener Granulomatosis
More general conditions related to this trial
Cardiovascular Diseases
Kidney Diseases
Lung Diseases
Lung Diseases, Interstitial
Respiratory Tract Diseases
Urologic Diseases
Vascular Diseases
Interventions listed in this trial
Azathioprine: 2 mg/kg/day
Additional drug interventions recognized in this trial
Azathioprine
Methotrexate
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Hospices Civils de Lyon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services